In this week’s edition of InnovationRx, we look at cheaper biologic drugs, Novo Nordisk’s $2 billion next-gen obesity drug deal, new ways of fighting cancer, and more.
With drug development costs topping $1.2bn (£850 million) to get a single treatment to the point it can be sold and used in the clinic, could genetic analysis save hundreds of millions of dollars?
HHS Secretary Robert F. Kennedy Jr., FDA Commissioner Marty Makary, MD, and CMS Administrator Mehmet Oz, MD, announced new FDA guidance aimed at making biosimilar drug development faster and less ...
Rare disease drug developers struggle to survive in a biopharma investment market that prioritizes large patient populations.
Overview Artificial intelligence seems to be transforming drug discovery in 2026, enabling faster molecule design, smarter clinical trials, and reduced R&D ...
The Brighterside of News on MSN
AI breakthrough could dramatically lower the cost of drug development
Three-letter DNA “words” can decide whether a yeast cell cranks out a medicine efficiently or sputters along. The words are ...
As President Donald Trump rolls out his TrumpRx proposal to cut prescription drug prices, economists are raising questions about what happens when prices are capped and whether short-term savings for ...
Pharma and life sciences GCCs reduce drug development timelines and costs by leveraging AI and automation, enhancing R&D efficiency.
AI could review data sets to assist clinical scientists ...
Add Yahoo as a preferred source to see more of our stories on Google. Oct. 30—In the absence of much federal action, states have enacted dozens of laws this year to lower prescription drug costs for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results